4 After-Hours Movers: Earnings, Strategic Reviews & Offerings Shaking Stocks
U.S. stocks tumbled on Thursday, largely driven by Apple Inc. (NASDAQ: AAPL)’s 1.55 percent decline, as well as a general drop in financial stocks triggered by worries about the financial health of Deutsche Bank AG (USA) (NYSE: DB).
After the market closed, Costco Wholesale Corporation (NASDAQ: COST) reported Q4 results. While revenue of $35.73 billion missed estimates by $1.08 billion, EPS of $1.77 beat the Street’s consensus by $0.04. Moreover, even though comps were flat year over year, underlying comps rose by 3 percent. Shares of Costco gained about 1.85 percent after the bell rang.
CalAmp Corp. (NASDAQ: CAMP) fell more than 11 percent after-hours, pushed by a revenue miss. Although EPS of $0.27 were in line with estimates, sales of $90.5 million missed expectations by $1.76 million. Q3 guidance was also disappointing, as management expects revenue in the $81 million to $87 million range, versus consensus at $95.01 million, and non-GAAP EPS of $0.24-$0.30, below estimates of $0.31.
ImmunoGen, Inc. (NASDAQ: IMGN) rose spiked 1.5 percent since the market closed. The rise came after the announcement of the completion of its strategic review, which led to the decision to fire 17 percent of its employees, and to find a development partner for its non-core B-cell lymphoma programs. Management said it anticipates the company will save $11 million per year.
VolitionRX Ltd (NYSE: VNRX) slipped 6.65 percent in Thursday’s after-hours session after reporting an offering of common shares, although neither the amount of shares nor the pricing were publicized.
Also after-hours, the Vetr crowd downgraded On Deck Capital Inc (NYSE: ONDK) from 4.5 Stars (Strong Buy) to 4.0 Stars (Buy), seeking to reflect a more limited upside potential. Shares of Vale SA (ADR) (NYSE: VALE) were also downgraded from 3.5 Stars (Buy) to 3.0 Stars (Hold); 50 percent of the crowd’s ratings are bullish at the time.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.